On Jan 29, 2026, SNY reported earnings of 1.53 USD per share (EPS) for Q4 25, beating the estimate of 1.46 USD, resulting in a 4.58% surprise. Revenue reached 11.30 billion, compared to an expected 11.54 billion, with a -2.08% difference. The market reacted with a +0.94% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 1.79 USD, with revenue projected to reach 10.36 billion USD, implying an increase of 16.99% EPS, and decrease of -8.31% in Revenue from the last quarter.
FAQ
What were Sanofi - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Sanofi - ADR reported EPS of $1.53, beating estimates by 4.58%, and revenue of $11.30B, -2.08% below expectations.
How did the market react to Sanofi - ADR's Q4 2025 earnings?
The stock price moved up 0.94%, changed from $45.77 before the earnings release to $46.20 the day after.
When is Sanofi - ADR expected to report next?
The next earning report is scheduled for Apr 23, 2026.
What are the forecasts for Sanofi - ADR's next earnings report?
Based on 4
analysts, Sanofi - ADR is expected to report EPS of $1.79 and revenue of $10.36B for Q1 2026.